Everolimus Eluting Coronary Stent Evermine50™ (continuación) - ARCSA Registration f4de5705c1e0eb6fbedb2aec37e9d871
Access comprehensive regulatory information for Everolimus Eluting Coronary Stent Evermine50™ (continuación) in the Ecuador medical device market through Pure Global AI's free database. This IV medical device is registered under ARCSA ID f4de5705c1e0eb6fbedb2aec37e9d871 and manufactured by MERIL LIFE SCIENCES PVT. LTD.. The device was registered on August 30, 2020.
This page provides complete registration details including product type (Invasive), manufacturer information, authorized representative details, and regulatory compliance data from the official Ecuador ARCSA medical device database. Pure Global AI offers free access to Ecuador's complete medical device registry.
THE EVERMINE 50 EVEROLIMUS ELUTING CORONARY STENT SYSTEM IS INDICATED TO IMPROVE CORONARY LUMINAL DIAMETER IN PATIENTS WITH SYMPTOMATIC ISCHEMIC HEART DISEASE IN PATIENTS ELIGIBLE FOR STENT PROCEDURES AND PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA).